Quick Answer
Inspire Medical Systems, Inc. reported Total Assets of $907.32 million for the year ending 2025.
- Inspire Medical Systems, Inc. showed an increase of +12.2% in Total Assets from 2024 to 2025.
- This data is from Inspire Medical Systems, Inc.'s annual report (Form 10-K), filed with the SEC on February 13, 2026.
- XBRL data for this metric is available from 2017 to 2025 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2018: $27.85 million | Q2 2018: $133.89 million | Q3 2018: $130.72 million | Q1 2019: $189.61 million | Q2 2019: $185.57 million | Q3 2019: $183.23 million | Q1 2020: $165.74 million | Q2 2020: $271.31 million | Q3 2020: $271.78 million | Q1 2021: $273.41 million | Q2 2021: $272.21 million | Q3 2021: $278.89 million | Q1 2022: $289.72 million | Q2 2022: $292.00 million | Q3 2022: $527.52 million | Q1 2023: $571.85 million | Q2 2023: $618.25 million | Q3 2023: $639.49 million | Q1 2024: $685.84 million | Q2 2024: $728.39 million | Q3 2024: $796.19 million | Q1 2025: $730.81 million | Q2 2025: $802.19 million | Q3 2025: $807.72 million.
- Over the full 9 years of available data (2017 to 2025), Inspire Medical Systems, Inc.'s Total Assets has grown by 3,516.1%.
- Historical annual values: Fiscal year 2025: $907.32 million | Fiscal year 2024: $808.38 million | Fiscal year 2023: $676.81 million | Fiscal year 2022: $564.88 million | Fiscal year 2021: $295.08 million | Fiscal year 2020: $281.19 million | Fiscal year 2019: $181.25 million | Fiscal year 2018: $200.08 million | Fiscal year 2017: $25.09 million.
- Data sourced from SEC EDGAR public filings as of August 7, 2026.
Last verified: